http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d8a058f88ce52d67ced98757d70380b7
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Stadler |
| name | Walter M. Stadler Walter M Stadler |
| given-name | Walter M Walter M. |
| organization-name | Department of Medicine, University of Chicago Comprehensive Cancer Center, The University of Chicago Medicine, Chicago, Illinois. Section of Hematology and Oncology, Comprehensive Cancer Center, The University of Chicago, Chicago, IL Authors' Affiliations: 1Cleveland Clinic, Cleveland, Ohio; 2Takeda Pharmaceuticals International Company; 3Millennium: The Takeda Oncology Company, Cambridge, Massachusetts; 4University of Chicago, Chicago; 5NorthShore University Health System, Evanston; 6Northwestern University Feinberg School of Medicine, Chicago, Illinois; 7Florida Cancer Specialists, Fort Myers, Florida; 8The Angeles Clinic & Research Institute, Los Angeles; 9University of Southern California Westside Cancer Center, Beverly Hills, California; and 10Sarah Cannon Cancer Research Institute, Nashville, Tennessee From the University of ChicagoMedical Center, Chicago, IL; Cancer and Leukemia Group B Statistical Center, Durham; Southeast Cancer Control Consortium Inc, CCOP, Goldsboro, NC; University of California at San Francisco, San Francisco, CA; University of Iowa, Iowa City, IA 1Committee on Cancer Biology;; 2Section of Urology, Department of Surgery; Departments of; 5University of Chicago Cancer Research Center;; 6Section of Hematology Oncology, Department of Medicine; and 7Department of Medicine, University of Chicago, Chicago, Illinois Authors' Affiliations: Departments of 1Medicine and 2Health Studies, 3Comprehensive Cancer Center, and 4Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, Illinois; 5Clinical Pharmacology Research Unit, Pfizer Inc, Groton, Connecticut; and 6Departments of Medicine and Medical Genetics, Indiana University School of Medicine, Indianapolis, Indiana; Authors' Affiliations: Departments of 1Medicine and 2Health Studies, 3Comprehensive Cancer Center, and 4Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, Illinois; 5Clinical Pharmacology Research Unit, Pfizer Inc, Groton, Connecticut; and 6Departments of Medicine and Medical Genetics, Indiana University School of Medicine, Indianapolis, Indiana All authors: University of Chicago, Chicago, IL. From the University of Chicago, Northwestern University, and Loyola University of Illinois, Chicago; Loyola University Medical Center, Maywood, IL; and Dana Farber Cancer Institute, Boston, MA. Department of Medicine, University of Chicago Medical Center, Chicago, Illinois. Maria I. Carlo and Wassim Abida, Memorial Sloan-Kettering Cancer Center; Himisha Beltran, Weill Cornell Medical Center; Jacob Vinson, Prostate Cancer Clinical Trials Consortium, New York, NY; Veda N. Giri, Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA; Channing J. Paller and Emmanuel S. Antonarakis, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Joshi J. Alumkal and Tomasz M. Beer, Oregon Health & Science University, Portland, OR; Daniel J. George... Genitourinary Oncology Program, Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago Illinois Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL. From the Beth Israel Deaconess Medical Center, Boston, MA; University of Texas Health Science Center at San Antonio, San Antonio, TX; University of Chicago, Chicago, IL; Indiana University, Indianapolis, IN; Our Lady of Mercy Cancer Center, NY Medical College, Bronx, NY; Fox Chase Cancer Center, Philadelphia, PA; and Wyeth Research, Cambridge, MA, and Collegeville, PA. University of Chicago Phase II Consortium, University of Chicago, Section of Hematology/Oncology, Chicago, Illinois 1Department of Medicine, Section of Hematology/Oncology,; 2University of Chicago Cancer Research Center,; 3Department of Surgery, Section of Urology, Department of Medicine University of Chicago Chicago Illinois USA Section of Hematology/Oncology University of Chicago Chicago Illinois Authors' Affiliations: 1The University of Chicago; 2Decatur Memorial Hospital, Decatur; 3Illinois Cancer Care, Peoria; 4Loyola University Medical Center, Maywood, Illinois; 5University of California, San Francisco, San Francisco; 6City of Hope, Duarte, California; 7University of Michigan Medical Center, Ann Arbor, Michigan; 8Medical College of Wisconsin, Milwaukee, Wisconsin; and 9National Cancer Institute, Rockville, Maryland Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL, USA Department of Medicine University of Chicago Medical Center Chicago Illinois From the Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; University of Wisconsin Carbone Comprehensive Cancer Center, Madison, WI; Fox Chase Cancer Center, Philadelphia, PA; University of Chicago, Chicago, IL; Pfizer Oncology, La Jolla, CA; Pfizer Oncology, New London, CT; and New York Medical College, New York, NY. From the University of Chicago, Chicago, IL. 15University of Chicago Medical Center, Chicago, Illinois; 7University of Chicago School of Medicine, Chicago, Illinois. Section of Hematology/Oncology, University of Chicago, Chicago, Illinois The University of Chicago Medical Center, Chicago, Illinois, USA. Authors' Affiliations: 1Section of Hematology/Oncology, Department of Medicine, 2Committee on Clinical Pharmacology and Pharmacogenomics, and 3Comprehensive Cancer Center Pharmacogenomics and Experimental Therapeutics Program, The University of Chicago, Chicago, Illinois; Authors' Affiliations: 1Section of Hematology/Oncology, Department of Medicine, 2Committee on Clinical Pharmacology and Pharmacogenomics, and 3Comprehensive Cancer Center Pharmacogenomics and Experimental Therapeutics Program, The University of Chicago, Chicago, Illinois Department of Medicine The University of Chicago Comprehensive Cancer Center, The University of Chicago Medicine Chicago Illinois USA University of Chicago Medicine, Chicago, IL, USA From the Departments of Urology, Pathology and Laboratory Medicine, Analytical Cytology Unit, University of Rochester Medical Center, Rochester, New York, and Section of Hematology/Oncology, Department of Medicine, Pritzker School of Medicine, University of Chicago, Chicago, Illinois. Daniel V.T. Catenacci, Theodore Karrison, James Wallace, Mark Kozloff, Peng Xu, Les Henderson, Ravi Salgia, Walter M. Stadler, Hedy L. Kindler, University of Chicago Medical Center; Patrick Stiff, Loyola University Medical Center, Chicago; Robert Marsh, Northshore University Health System, Evanston; James Wallace, Mark Kozloff, Ingalls Hospital, Harvey; James Wade, Decatur Memorial Hospital, Decatur; Pankaj Kumar, Oncology/Hematology Associates, Peoria, IL; Melissa R. Junttila, Xi Wang, and Frederic J.... Section of Hematology/Oncology Department of Medicine University of Chicago Chicago Illinois From the Section of Hematology/OncologyUniversity of Chicago Hospitals; University of Chicago Cancer Research Center, Chicago; Decatur Memorial Hospital, Decatur, IL; and Memorial Hospital, South Bend, IN. Department of Medicine/Section of Hematology/Oncology University of Chicago Chicago Illinois USA Hematology/Oncology Section The University of Chicago Chicago Illinois Section Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, Illinois William Kevin Kelly, Thomas Jefferson University, Philadelphia, PA; Susan Halabi and Daniel George, Duke University Medical Center; Susan Halabi and Ellen Kaplan, Cancer and Leukemia Group B Statistical Center, Duke University Medical Center, Durham; John F. Mahoney, Carolinas Medical Center, Charlotte, NC; Michael Carducci, The Johns Hopkins University, Baltimore, MD; Walter M. Stadler, University of Chicago, Chicago, IL; Michael Morris, Memorial Sloan-Kettering Cancer Center, New York, NY; Philip... Authors' Affiliations: 1Section of Hematology/Oncology, Department of Medicine; 2Committee on Clinical Pharmacology and Pharmacogenomics; 3Cancer Research Center; and 4Department of Health Studies, University of Chicago; 5Department of Preventive Medicine, Rush University Medical Center, Chicago, Illinois; 6Kansas University Medical Center, Kansas City, Kansas; and 7Division of Nephrology and Hypertension, Department of Medicine, New York University School of Medicine, New York, New York; Authors' Affiliations: 1Section of Hematology/Oncology, Department of Medicine; 2Committee on Clinical Pharmacology and Pharmacogenomics; 3Cancer Research Center; and 4Department of Health Studies, University of Chicago; 5Department of Preventive Medicine, Rush University Medical Center, Chicago, Illinois; 6Kansas University Medical Center, Kansas City, Kansas; and 7Division of Nephrology and Hypertension, Department of Medicine, New York University School of Medicine, New York, New York University of Chicago, Department of Medicine, Chicago, IL Department of Hematology/Oncology, MC 2115, The University of Chicago, 5841 S. Maryland Ave, Chicago, IL 60637 The University of Chicago Medicine, Chicago, IL, USA. 5University of Chicago, Chicago, Illinois; and From the Section of Hematology/Oncology, Department of Medicine, and the Cancer Research Center, University of Chicago, Chicago, IL; and Michiana Hematology/Oncology, Northern Indiana Cancer Research Consortium, South Bend, IN. 8The University of Chicago Medical Center, Chicago, Illinois. 1Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, Illinois. Department of Medicine, University of Chicago Chicago, IL USA From the University of California San Francisco, Comprehensive Cancer Center, San Francisco, CA; Section of Hematology/Oncology, The University of Chicago Hospitals and University of Chicago Cancer Research Center, Chicago, IL. Russell Z. Szmulewitz, Abiola Ibraheem, Elia Martinez, Mark F. Kozloff, Chadi Nabhan, Theodore Karrison, Walter M. Stadler, and Mark J. Ratain, The University of Chicago, Chicago; Mark F. Kozloff, Ingalls Hospital, Harvey; Paul Fishkin, Illinois Cancer Care, Peoria, IL; Cody J. Peer and William D. Figg, National Cancer Institute, Rockville, MD; Bradley Carthon and R. Donald Harvey, Winship Cancer Institute of Emory University, Atlanta, GA; and Wei Peng Yong and Edmund Chiong, National University Cancer... From the University of Chicago and University of IllinoisChicago, IL; M.D. Anderson Cancer Center, Houston, TX; and Michiana Hematology/Oncology, South Bend, IN. Department of Medicine (Hematology/Oncology), University of Chicago, Chicago, IL, USA Division of Hematology/Oncology University of Chicago Chicago Illinois University of Chicago, Chicago, IL From the Departments of Medicine, Sections of Geriatrics and Palliative Medicine and Hematology/Oncology, University of Chicago, Chicago, IL; Department of Neoplastic Diseases and Related Disorders, Medical College of Wisconsin, Milwaukee, WI; and Department of Medicine, James P. Wilmot Cancer Center, University of Rochester, Rochester, NY. 6University of Chicago, Chicago, Illinois; From the From Institut Gustave Roussy, Villejuif; Hôpital Européen Georges Pompidou, Paris; Centre Léon Bérard, Lyon; Institut Claudius Regaud, Toulouse; Centre René Gauducheau, Saint-Herblain, France; Cambridge Research Institute, Cambridge; Royal Marsden Hospital, Surrey, United Kingdom; Military School of Medicine; Centrum Onkologii, Warsaw, Poland; Urologische Klinik und Poliklinik Klinikum der Universität Großhadern Ludwig-Maximilian-Universität, München, Germany; University of Chicago, Chicago, IL;... From the Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Department of Biostatistics and Bioinformatics, Duke University Medical Center, and Cancer and Leukemia Group B Statistical Center, Durham; Southeast Cancer Control Consortium Inc, Winston-Salem, NC; University of California at San Francisco, San Francisco, CA; University of Chicago Medical Center, Chicago, IL; University of Iowa, Iowa City, IA; Washington University, St Louis, MO; CancerCare Manitoba, Winnipeg, Manitoba, and the National... Roberto Pili, Roswell Park Cancer Institute, Buffalo, NY; Michael Häggman, University Hospital of Uppsala, Uppsala; Anders Björk, Örjan Nordle, and Goran Forsberg, Active Biotech, Lund, Sweden; Walter M. Stadler, University of Chicago, Chicago, IL; Jeffrey R. Gingrich, University of Pittsburgh, Pittsburgh, PA; Vasileios J. Assikis, Peachtree Hematology Oncology Consultants, Atlanta, GA; Michael A. Carducci, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD; and Andrew J.... Department of Medicine The University of Chicago Chicago Illinois Section of Hematology/Oncology, Department of Medicine, University of Chicago, Maryland Avenue, MC2115, Chicago, IL 60637, USA Russell Z. Szmulewitz, Theodore Karrison, Walter M. Stadler, and Mark J. Ratain, The University of Chicago, Chicago, IL Boston City Hospital and New England Deaconess Hospital, Boston, Cambridge Urological Associates, Cambridge, Matritech, Inc., Newton and Medical/Science Analytics, Brookline, Massachusetts, University of Chicago, Weiss Memorial Hospital and Dupage Urological Associates, Chicago, Illinois, West Virginia University, Morgantown, West Virginia, University of Washington, Seattle, Washington, University of Rochester, Rochester, New York, Medical College of Pennsylvania and Hahnemann University,... Hedy L. Kindler, Theodore G. Karrison, Samuel G. Armato III, Nicholas J. Vogelzang, Walter M. Stadler, and Everett E. Vokes, University of Chicago Comprehensive Cancer Center, Chicago; Kathy S. Albain, Loyola University, Maywood, IL; David R. Gandara, University of California at Davis, Sacramento; David I. Quinn, University of Southern California, Los Angeles; Marianna N. Koczywas, City of Hope Medical Center, Duarte, CA; Charles Lu, The University of Texas MD Anderson Cancer Center, Houston, TX; Lee M.... University of Miami, Miami, Florida; Matritech, Inc., Newton, Boston City Hospital and New England Deaconess Hospital, Boston, and Cambridge Urological Associates, Cambridge, Massachusetts; Weiss Memorial Hospital and University of Chicago, Chicago, and Dupage Urological Associates, Naperville, Illinois; West Virginia University, Morgantown, West Virginia; University of Washington, Seattle, Washington; University of Rochester, Rochester, New York; Medical College of Pennsylvania and Hahnemann... Noura J. Choudhury, Alexa Campanile, Tatjana Antic, Kai Lee Yap, Carrie A. Fitzpatrick, Theodore Karrison, Walter M. Stadler, Yusuke Nakamura, and Peter H. O’Donnell, University of Chicago, Chicago; and James L. Wade III, Decatur Memorial Hospital, Decatur, IL. From the University of California San Francisco, San Francisco, and US Naval Medical Center, University of California San Diego, San Diego, CA; Cancer and Leukemia Group B Statistical Center, Duke University Medical Center, Durham, and Wake Forest Comprehensive Cancer Center, Winston-Salem, NC; Greenebaum Cancer Center, University of Maryland, Baltimore, MD; University of Chicago Medical Center, Chicago, IL; and Washington University Barnard Cancer Center, St Louis, MO From the Sections of Hematology/Oncology, Otolaryngology-Head and Neck Surgery, and Urology, and Departments of Medicine, Pathology, Surgery, Health Studies, and Radiation and Cellular Oncology, University of Chicago; and Section of Hematology/Oncology, Department of Medicine, University of Illinois-Chicago, Chicago, IL. From the Section of Hematology/Oncology, University of Chicago Medical Center; Cancer Research Center; Department of Health Studies; Department of Radiology, University of Chicago, Chicago; Evanston Hospital, Evanston; Ingalls Hospital, Harvey, IL; Fort Wayne Medical Center, Fort Wayne; and Northern Indiana Cancer Research Consortium, South Bend, IN From the University of Chicago, Chicago, IL; Royal Marsden Hospital, Surrey, United Kingdom; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; The University of Texas M.D. Anderson Cancer Center, Houston; Cancer Therapy and Research Center, San Antonio, TX; Bayer Pharmaceuticals Corporation, West Haven, CT Section of Hematology Oncology University of Chicago Chicago Illinois From the Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Massachusetts General Hospital, Boston, MA; University of California, San Francisco; City of Hope, Los Angeles; Pfizer Global Research and Development, La Jolla, CA; Vanderbilt University, Nashville, TN; University of Chicago, Chicago, IL; Baylor-Sammons/Texas Oncology, Dallas, TX; and Duke University Medical Center, Durham, NC From the University of Chicago, Chicago, IL University of Chicago, Chicago, Illinois From the Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Department of Biostatistics and Bioinformatics, Duke University Medical Center; Cancer and Leukemia Group B Statistical Center, Durham; Southeast Cancer Control Consortium, Winston-Salem, NC; University of California San Francisco, San Francisco, CA; University of Chicago Medical Center, Chicago, IL; University of Iowa, Iowa City, IA; Washington University, St Louis, MO; New York Medical College, New York, NY; Eastern Cooperative Oncology... 2Medicine, and; 4Cancer Research Center, and University of Chicago Comprehensive Cancer Center, Chicago, IL Russell Z. Szmulewitz, Walter M. Stadler, and Mark J. Ratain, The University of Chicago, Chicago, IL Section of Hematology/Oncology Department of Medicine University of Chicago Chicago IL USA 2Cancer Research Center,; 4Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois and Department of Medicine Section of Hematology‐Oncology University of Chicago Chicago IL USA 3University of Chicago, Chicago, Illinois. Maha Hussain, Robert H. Lurie Comprehensive Cancer Center, Northwestern University; Walter M. Stadler, University of Chicago, Chicago; Daniel H. Shevrin, NorthShore University Health System, Evanston, IL; Maha Hussain, Stephanie Daignault-Newton, Lakshmi P. Kunju, Javed Siddiqui, Yi-Mi Wu, Dan Robinson, Robert J. Lonigro, Xuhong Cao, Scott A. Tomlins, Rohit Mehra, David C. Smith, Megan V. Caram, and Arul M. Chinnaiyan, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Przemyslaw W.... University of Chicago Medicine, Comprehensive Cancer Center, Chicago, Illinois Department of Medicine Section of Hematology/Oncology University of Chicago Chicago IL USA University of Chicago, Department of Medicine, Section Hematology Oncology, Chicago, IL Walter M. Stadler and Gary Steinberg, University of Chicago, Chicago, IL; Seth P. Lerner, Baylor College of Medicine, Houston, TX; Susan Groshen, University of Southern California; John P. Stein, Shan-Rong Shi, and Donald G. Skinner, University of Southern California Keck School of Medicine, Los Angeles, CA; Derek Raghavan, Levine Cancer Institute, Carolinas HealthCare System, Charlotte; Craig Hall, Piedmont Urologic Associates, High Point, NC; David Esrig, Oregon Urology Institute, Springfield, OR;... Authors' Affiliation: University of Chicago, Chicago, Illinois Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, Illinois Department of Medicine, Section Hematology/Oncology, University of Chicago, Chicago, IL |
Incoming Links
Total number of triples: 331.